Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.55
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.20
Today|||52-Week Range
17.04
-70.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.003.2M145.0K
 
 
 
Depreciation And Amortization353.0K344.0K285.0K266.0K
 
 
 
 
 
 
Operating ExpensesGross Income-353.0K-344.0K----
 
 
 
General Expenses27.9M28.1M40.8M57.3M
 
 
 
 
 
Research And Development21.7M21.8M33.5M46.5M
 
 
 
 
 
Total Operating Expenses28.2M28.5M41.1M57.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.2M-28.5M-37.9M-57.4M
 
 
 
 
 
Extraordinary Credit0.000.000.001.7M
 
 
Interest Expense On Debt2.6M1.0M0.000.00
 
 
 
Other Expenses-15.0K-96.0K2.7M171.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.9M-29.6M-35.2M-55.5M
 
 
 
 
 
Preferred Dividend0.000.000.00-10.9M
 
 
Net Income-30.9M-29.6M-35.2M-55.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.3M2.7M4.5M5.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.3M2.7M4.5M5.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.52-$10.88-$7.92-$12.88
 
 
 
 
 
EPS Diluted-$13.52-$10.88-$7.92-$12.88